The common sexually transmitted infection can cause infertility in women and is responsible for vision loss in an estimated 1.9 million people worldwide.
An early-stage clinical trial has come back with promising results for a chlamydia vaccine, researchers have said. There is currently no jab to protect against the disease, which is one of the most common sexually transmitted infections in the UK. Almost 200,000 cases were identified in England alone in 2022, a nearly 25% rise from the year before, according to latest NHS figures. Chlamydia is a common cause of infertility in women.
Read more:STI rates soar in UKGonorrhoea and syphilis diagnoses hit record levelsNew test for 'most common STI you've never heard of' Although the vaccine induced an immune response, Dr Hilary Reno, medical director of the St Louis County Sexual Health Clinic, said questions remained about its effectiveness.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
It's tax season, and scammers are a step ahead of filers, Microsoft saysPhishing season started early with crims intent on the hooking early filers
Read more »
From persistent varicose veins to a ‘tired brain’ – Dr Zoe Williams answers your health questions...What is hay fever: Hayfever season strikes early as mild winter sparks early pollen ‘explosion’
Read more »
Adding vaccine to immunotherapy for liver cancer shows promise in early trialA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Read more »
Research highlights importance of support reciprocity during early-stage dementia careIn cases of Alzheimer's disease, it's common for a spouse to take on the role of caregiver. Research led by the University of California, Davis, suggests that patients can also support their caretakers, and that reciprocated care has mutual benefits.
Read more »
Combined scanning technique could refine treatment for early-stage breast cancer patientsUsing a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial presented at the 14th European Breast Cancer Conference today.
Read more »
Founder Labs programme targets early stage tech companies with £5M supportThe programme will support 40 businesses over the next four years
Read more »